Jean-Pierre Sommadossi insider trades

Open-market stock purchases and sales by Jean-Pierre Sommadossi, President, CEO, and Chairman at Atea Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 10, 2010.

Recent trades

DateStockTradeValue
Feb 3, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncSold (not open market)$450K
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AVIR Atea Pharmaceuticals, Inc: 5 sales, last Feb 3, 2026
  • ABGI ABG Acquisition Corp I: other filings, last Mar 1, 2023
  • KZR Kezar Life Sciences, Inc: other filings, last Jun 28, 2021
  • IDIX Idenix Pharmaceuticals Inc: other filings, last Feb 10, 2010

Get free alerts when Jean-Pierre Sommadossi files a new trade →